Integra LifeSciences Holdings Corporation
IART
$15.10
-$0.02-0.13%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 265.50M | 263.74M | 267.88M | 253.61M | 273.30M |
| Total Receivables | 264.41M | 278.85M | 262.16M | 284.51M | 252.45M |
| Inventory | 495.04M | 492.74M | 489.11M | 465.13M | 445.42M |
| Prepaid Expenses | 97.71M | 96.09M | 94.11M | 103.47M | 103.87M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 49.35M | 28.13M | 30.33M | 36.12M | 32.21M |
| Total Current Assets | 1.17B | 1.16B | 1.14B | 1.14B | 1.11B |
|
|
|||||
| Total Current Assets | 1.17B | 1.16B | 1.14B | 1.14B | 1.11B |
| Net Property, Plant & Equipment | 584.08M | 584.90M | 575.55M | 571.39M | 561.38M |
| Long-term Investments | 613.25M | 615.16M | 615.20M | 616.43M | 1.11B |
| Goodwill | 613.25M | 615.16M | 615.20M | 616.43M | 1.11B |
| Total Other Intangibles | 1.11B | 1.13B | 1.16B | 1.19B | 1.19B |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 90.89M | 94.99M | 136.43M | 130.68M | 64.27M |
| Total Assets | 3.58B | 3.60B | 3.65B | 3.67B | 4.05B |
|
|
|||||
| Total Accounts Payable | 87.95M | 95.73M | 92.31M | 92.84M | 91.30M |
| Total Accrued Expenses | 181.63M | 164.50M | 200.03M | 180.72M | 187.59M |
| Short-term Debt | -- | 87.80M | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 53.72M | 53.87M | 53.72M | 628.73M | 627.76M |
| Total Finance Division Other Current Liabilities | 23.55M | 54.09M | 18.00M | 27.52M | 11.81M |
| Total Other Current Liabilities | 23.55M | 54.09M | 18.00M | 27.52M | 11.81M |
| Total Current Liabilities | 346.85M | 455.98M | 364.05M | 929.81M | 918.45M |
|
|
|||||
| Total Current Liabilities | 346.85M | 455.98M | 364.05M | 929.81M | 918.45M |
| Long-Term Debt | 1.83B | 1.73B | 1.79B | 1.23B | 1.23B |
| Short-term Debt | -- | 87.80M | -- | -- | -- |
| Capital Leases | 160.12M | 163.06M | 160.93M | 159.27M | 161.48M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 201.32M | 209.42M | 290.82M | 312.44M | 217.09M |
| Total Liabilities | 2.54B | 2.56B | 2.61B | 2.63B | 2.53B |
|
|
|||||
| Common Stock & APIC | 1.34B | 1.34B | 1.33B | 1.33B | 1.32B |
| Retained Earnings | 418.82M | 423.44M | 425.15M | 430.55M | 914.62M |
| Treasury Stock & Other | -718.06M | -719.29M | -722.00M | -720.94M | -714.49M |
| Total Common Equity | 1.04B | 1.04B | 1.04B | 1.04B | 1.52B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.04B | 1.04B | 1.04B | 1.04B | 1.52B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.04B | 1.04B | 1.04B | 1.04B | 1.52B |
|
|
|||||